Table 1.
Experiment | Section in text | Primary Ab combination |
---|---|---|
i) Initial determination of lumbar spinal cord leukocyte infiltration | section 2.2 | PE-anti-mouse CD45 |
ii) Phenotypic analysis of lumbar spinal cord infiltrating and splenic leukocytes | section 2.2 and section 2.3 data not shown | Tube 1) APC-Cy7-anti-mouse CD45, perCP (or PE-Cy7)-anti-mouse CD3, FITC-anti-mouse CD4, PE-anti-mouse CD8; Tube 2) APC-Cy7-anti-mouse CD45, perCP-anti-mouse CD3, FITC-anti-mouse panNK, PE-anti-mouse CD19; Tube 3) APC-Cy7-anti-mouse CD45, perCP-anti-mouse CD3, FITC-anti-mouse CD11b, PE-anti-mouse I-Ad. |
iii) Phenotypic analysis of CD4+ T lymphocytes in spleen and lumbar lymph nodes | Section 2.3 | Tube 1)APC-Cy7-anti-mouse CD45, PE-Cy7-anti-mouse CD3, FITC-anti-mouse CD4, Biotin-anti-mouse CD45RB; Tube 2)a APC-Cy7-anti-mouse CD45, PE-Cy7-anti-mouse CD3, FITC-anti-mouse CD4, PE-anti-mouse CD40L, Biotin-anti-mouse CD69. |
for lymph nodes, only tube 1 was used due to the limited numbers of cells available.
All mAbs were from BD Biosciences (San Diego, CA) except that Biotin-anti-mouse CD69 was from eBioscience (San Diego, CA).